CNBCLean R·
This biotech is leading what could be a 'GLP-1 moment for hair loss,' says BTIG
BTIG initiated research coverage with a buy rating, calling the biotech's experimental hair loss treatment a possible 'GLP-1 moment.'
Read at CNBC →
Business · 1 sources covering this
This biotech is leading what could be a 'GLP-1 moment for hair loss,' says BTIG
BTIG initiated research coverage with a buy rating, calling the biotech's experimental hair loss treatment a possible 'GLP-1 moment.'
Coverage spectrum
0 L · 0 C · 1 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/2870b8d5911810f3d5fbef603aa29cee6c0adc36" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="This biotech is leading what could be a 'GLP-1 moment for hair loss,' says BTIG"></iframe>
